Clinical trial
The UC Davis Cohort of Pre-Malignant and Malignant GastroIntestinal DisEases (TUMMIE) Study
NCT05021029 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The UC Davis Cohort of Pre-Malignant and Malignant GastroIntestinal DisEases (TUMMIE) Study
- Lead sponsor
- University of California, Davis
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 13, 2021
- Completion date
- October 31, 2030
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrophic gastritis, autoimmune gastritis, chronic gastritis, gastric polyps, intestinal dysplasia, intestinal metaplasia